Introducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier

Keyphrases

• Colorectal Cancer 100%
• Neoadjuvant Immunotherapy 100%
• Cancer Types 40%
• Mismatch Repair 40%
• Deficient Mismatch Repair (dMMR) 40%
• Clinical Characteristics 20%
• Immune Response 20%
• Delayed Diagnosis 20%
• Narrative Review 20%
• Surgeons 20%
• Response Pattern 20%
• Survival Outcomes 20%
• Improved Survival 20%
• Oncology 20%
• Genetic Modification 20%
• Tumor Microenvironment 20%
• Standard of Care 20%
• Biomarker Testing 20%
• Complete Response Rate 20%
• Response Prediction 20%
• Radiological Assessment 20%
• Watch-and-wait 20%
• Heterogeneity in Responses 20%
• POLE mutation 20%
• Organ Sparing 20%
• Immune Checkpoint Inhibitors 20%
• Clonal Heterogeneity 20%
• Tumor Genetics 20%
• Response to Immunotherapy 20%

Medicine and Dentistry

• Colorectal Cancer 100%
• Immunotherapy 100%
• DNA Mismatch Repair 25%
• Cancer Types 16%
• Malignant Neoplasm 8%
• Biological Marker 8%
• Surgeon 8%
• Oncology 8%
• Gene Mutation 8%
• Immune Response 8%
• Tumor Microenvironment 8%
• Immune Checkpoint Inhibitor 8%

Immunology and Microbiology

• Immunotherapy 100%
• Mismatch Repair 25%
• Immune Response 8%
• Gene Mutation 8%